Fluticasonedrug info
120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler
What it is used for
Fluticasone propionate inhalation aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients aged 4 years and older. Limitations of Use Fluticasone propionate inhalation aerosol is not indicated for the relief of acute bronchospasm. Fluticasone propionate inhalation aerosol is an inhaled corticosteroid indicated for:
Maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients aged 4 years and older. Limitations of use: Not indicated for relief of acute bronchospasm.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective March 25, 2026. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
Description
Fluticasone Propionate Inhalation Aerosol USP is a pressurized metered dose inhaler for oral inhalation. The active component of Fluticasone Propionate 44 mcg Inhalation Aerosol is fluticasone propionate, USP, a corticosteroid having the chemical name S -Fluoromethyl 6α,9α-difluoro-11 β -hydroxy-16α-methyl-3-oxo-17α-propionyloxyandrosta-1,4-diene-17 β -carbothioate and the following chemical structure: Fluticasone propionate, USP is a fine, white powder with a molecular weight of 500.57, and the empirical formula is C 25 H 31 F 3 O 5 S. It is practically insoluble in water, sparingly soluble in methylene chloride and slightly soluble in alcohol. Fluticasone Propionate Inhalation Aerosol USP is a white plastic inhaler with a dose counter and maroon cap containing a pressurized metered-dose aerosol canister. Each canister contains a microcrystalline suspension of micronized fluticasone propionate, USP in propellant HFA-134a (1,1,1,2- tetrafluoroethane). It contains no other excipients. After priming, each actuation of the inhaler delivers 50 mcg of fluticasone propionate, USP in 60 mg of suspension from the valve. Each actuation delivers 44 mcg of fluticasone propionate, USP from the actuator. The actual amount of drug delivered to the lung will depend on patient factors, such as the coordination between the actuation of the inhaler and inspiration through the delivery system. Prime Fluticasone Propionate Inhalation Aerosol USP before using for the first time by releasing 4 sprays into the air away from the face, shaking well for 5 seconds before each spray. In cases where the inhaler has not been used for more than 7 days or when it has been dropped, prime the inhaler again by shaking well for 5 seconds and releasing 1 spray into the air away from the face. Avoid spraying in eyes. structure
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective March 25, 2026. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance